OM DENNE EPISODE

Engelsk
USA

UDSKRIFT 🔗

SØG BLANDT TIDLIGERE EPISODER

Søg efter gamle afsnit af PharmaSource Podcast.

ANDRE EPISODE I DENNE PODCAST

“If the data you give it is weak, the model becomes a liability rather than an asset. In regulated industries, that’s not just a technical failure; it’s potentially a compliance and an ethical failure as well,” says Amie Harpe. Amie Harpe spent 23 years at Pfizer’s global IT organization, leading q…
“To us, it’s exactly the opposite of a marketing slogan. If we make a decision that has a negative impact on a patient, we’ve made a bad decision,” says Stuart Needleman. Stuart Needleman is Chief Commercial Officer and Chief Patient Centricity Officer at Piramal Pharma Solutions. Before Piramal, h…
At CDMO Live Europe 2026, Alexander Schäfer, Business Development Manager at Sharp, laid out the scale of the GLP-1 packaging challenge and identified the three collaboration failures most likely to prevent CDMOs and their pharma partners from meeting surging demand. Read the full article.
Container closure integrity (CCI) is a critical element of sterile product quality, but evaluating a CDMO’s CCI capabilities requires more than confirming that testing is available. The appropriate approach depends on the drug product, container closure system, manufacturing process, lifecycle risk…
At CDMO Live Europe 2026, Giulio Cavalli, Principal Lead External Manufacturing, J&J Innovative Medicine; Neil Stevenson, Director, CMC Logic Consultancy; Marine Joly Battaglini, Founder, PharmDev; and Susan Reasoner, Chief Commercial Officer, BioDuro, examined how early-stage biotechs can avoi…
Ansvarsfraskrivelse: Podcasten og kunstværket, der er indlejret på denne side, er fra Life Science Networks, som tilhører dens ejer og ikke er tilknyttet eller godkendt af Listen Notes, Inc.